Tom G. Vadaketh - 05 Sep 2023 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Reporting relationship: EVP, Chief Financial Officer
Issuer ticker: BHC
Reported as of: 05 Sep 2023
Net transaction value: -$366,966
SEC form: 4
Accepted by SEC: 06 Sep 2023, 16:29:54 UTC
Prior SEC filing: 21 Mar 2023
Next SEC filing: 24 Oct 2023
Source filing: View source filing
Reporting owner signature: /s/ Brianna M. Cetrulo, attorney-in-fact

Key filing fact

Tom G. Vadaketh filed Form 4 for Bausch Health Companies Inc. (BHC) on 06 Sep 2023.

Key facts

This page summarizes Tom G. Vadaketh's Form 4 filing for Bausch Health Companies Inc. (BHC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Sep 2023, 16:29.

Change

Previous filing in this sequence was filed on 21 Mar 2023.
Current net transaction value: -$366,966.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BHC transaction

Common Shares, No Par Value

Tax liability

Transaction value: $366,966
Shares: -43,948
Change %: -7.2%
Price: $8.35
Shares after: 564,933
Date: 05 Sep 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.